Current enzyme replacement therapy for the treatment of lysosomal storage diseases.
Lim-Melia
Elizabeth R
ER
Regional Medical Genetics Center, N.Y. Medical College, Valhalla, NY 10595, USA. Elizabeth_LimMelia@nymc.edu
Kronn
David F
DF
D057487:Enzyme Therapy; D000795:Fabry Disease / Q000188:drug therapy; D005776:Gaucher Disease / Q000188:drug therapy; D005962:Glucosylceramidase / Q000627:therapeutic use; D006009:Glycogen Storage Disease Type II / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D007527:Isoenzymes / Q000627:therapeutic use; D020140:Lysosomal Storage Diseases, Nervous System / Q000175:diagnosis / Q000188:drug therapy*; D009083:Mucopolysaccharidoses / Q000188:drug therapy; D020051:N-Acetylgalactosamine-4-Sulfatase / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D000519:alpha-Galactosidase / Q000627:therapeutic use
D007527:Isoenzymes; D011994:Recombinant Proteins; D020051:N-Acetylgalactosamine-4-Sulfatase; C508864:galsulfase; D000519:alpha-Galactosidase; D005962:Glucosylceramidase; C090568:imiglucerase; C459420:agalsidase beta